VERTEX PHARMACEUTICALS INCORPORATED

Trading Ideas Vertex Pharmaceuticals Incorporated

Equities

VRTX

US92532F1003

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
455.3 ^USD	+2.77%		-0.35%	+11.91%

May. 31	BMO Capital Adjusts Price Target on Vertex Pharmaceuticals to $500 From $480	MT
May. 31	Vertex Pharmaceuticals Insider Sold Shares Worth $1,478,068, According to a Recent SEC Filing	MT

Trading Ideas

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

VERTEX PHARMACEUTICALS INCORPORATED :The technical configuration is positive	22-01-10
VERTEX PHARMACEUTICALS INCORPORATED :The underlying trend is to the upside	20-08-03
VERTEX PHARMACEUTICALS INCORPORATED :The trend should continue	20-06-24
VERTEX PHARMACEUTICALS INCORPORATED :Buyers are coming back	20-03-05

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Vertex Pharmaceuticals Incorporated : Vertex and Crispr to market $2.2 million treatment for sickle cell disease

Vertex Pharmaceuticals Incorporated : Vertex and Crispr to market $2.2 million treatment for sickle cell disease

December 11, 2023 at 05:47 am EST

Stock Market
Equities
VRTX Stock
News Vertex Pharmaceuticals Incorporated
Trading Ideas

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer